Non-Drug Eluting Device Market Analysis Report 2024: Global Size, Trends, Opportunities And Forecasts 2020-2030

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Oct. 31, 2024 (GLOBE NEWSWIRE) -- The "Non-Drug Eluting Device Market: market Size, Trends, Opportunities and Forecast by Application, Material Type, End-User, Region, By Country: 2020-2030" report has been added to ResearchAndMarkets.com's offering.
Global Non-Drug Eluting Device Market was valued at USD 6.52 billion and is expected to grow at a CAGR of 5.3% during 2025-2030.
The Non-Drug Eluting Device Market is witnessing steady growth, primarily driven by the increasing demand for medical devices that do not rely on drug delivery mechanisms but are crucial in managing various medical conditions. Non-drug eluting devices, such as bare-metal stents, catheters, and implantable medical devices, are widely used in procedures where drug elution is not necessary, or where a more mechanical or structural intervention is required. These devices play a key role in the treatment of cardiovascular diseases, orthopedic conditions, and general surgeries.
In the cardiovascular sector, bare-metal stents remain in use for certain patient populations, despite the widespread adoption of drug eluting stents. These stents offer structural support to arteries without releasing drugs, making them suitable for patients who may not benefit from drug elution or those at risk of complications. The demand for non-drug eluting devices is also growing in the orthopedic sector, where devices such as spinal implants and joint replacements are critical for treating musculoskeletal disorders and injuries.
Moreover, advancements in material science and engineering have led to the development of more durable, biocompatible, and patient-friendly non-drug eluting devices. The increasing focus on minimally invasive surgical procedures, which often rely on non-drug eluting devices like catheters and guidewires, has further driven market growth. As healthcare systems worldwide aim to improve patient outcomes and reduce recovery times, the adoption of these devices is expected to continue rising.
The cardiovascular segment dominates the Non-Drug Eluting Device Market, representing around 50% of the market in 2023. Bare-metal stents and other cardiovascular devices remain essential for certain patient groups.
The Americas dominate the Non-Drug Eluting Device Market, largely due to the high prevalence of cardiovascular diseases, advanced healthcare infrastructure, and ongoing innovations in medical device technologies. The Asia-Pacific region is also experiencing significant growth, driven by rising healthcare expenditure and increasing demand for minimally invasive procedures.

Reasons to buy this report:

• In-Depth Comparative Assessment of Top 20 Markets in the Non-Drug Eluting Device Market Material Type: Comparative assessment of 20 leading countries highlighting the total addressable market, opportunities, lucrative segments and competitive positioning of leading companies.
• Comprehensive Historical, Present, and Future Analytics of the Non-Drug Eluting Device Market: A deep dive in the historical (2020-2023), current (2024) and forecast (2025-2030) market analytics of Non-Drug Eluting Device Market.
• Detailed Analysis of Non-Drug Eluting Device Market By Application, Material Type, and End-User Across 20 Countries
• Beyond the Purchase: 90 Days of Support
• Direct Access to Analysts: Have questions after reading the report? Our expert analysts are just a call or email away.
• Customized Assistance: Whether you're integrating insights into your strategy or have questions about market dynamics, our team provides tailored support to meet your specific business needs.
• Data Customization Requests: During the support period, you have the flexibility to request additional data cuts or deeper dives into specific areas of interest.
• Gain insights specific to new entrants or new market areas to tap: The study provides detailed market entry strategies, including analysis of barriers to entry, pricing strategies, opportunities, trends, drivers, and challenges and product positioning using the Opportunity Portfolio Matrix (OPM)
• Strategic Movements: Tracking Competitive Developments and Key Players in the Market

Key Companies

• Smith & Nephew plc.
• Integra Lifesciences
• ConMed Corporation
• Peter Surgical
• Boston Scientific Corporation
• DemeTECH Corporation
• Teleflex Incorporated
• Medtronic
• Stryker Corporation
• B. Braun Melsungen AG
• Johnson & Johnson Services Inc.

Key Topics Covered:
1. Market Background
1.1 Scope and Product Outlook
1.2 Executive Summary
1.3 Research Methodology
2. Analyst Recommendations
3. Global Non-Drug Eluting Device Market: Historic and Forecast
3.1 Impact Analysis of Macro Economic Factors on Global Non-Drug Eluting Device Market
3.2 Non-Drug Eluting Device Market Type Matrix
3.3 Global Non-Drug Eluting Device Market: Dashboard
3.4 Global Non-Drug Eluting Device Market: Market Size and CAGR, By Value, 2020-2030 (USD Million & CAGR)
3.5 Global Non-Drug Eluting Device Market: Market Value Assessment
3.6 Assessment Degree of Impact of COVID-19 on Global Non-Drug Eluting Device Market
3.7 Global Non-Drug Eluting Device Market Segmentation: By Application
3.7.1 Global Non-Drug Eluting Device Market, By Application Overview
3.7.2 Global Non-Drug Eluting Device Market Attractiveness Index, By Application (2025-2030)
3.7.3 Global Non-Drug Eluting Device Market Size, By Cardiovascular Diseases, By Value, 2020H-2030F (USD Million & CAGR)
3.7.4 Global Non-Drug Eluting Device Market Size, By Peripheral Artery Disease, By Value, 2020H-2030F (USD Million & CAGR)
3.7.5 Global Non-Drug Eluting Device Market Size, By Oncology, By Value, 2020H-2030F (USD Million & CAGR)
3.7.6 Global Non-Drug Eluting Device Market Size, By Urology, By Value, 2020H-2030F (USD Million & CAGR)
3.7.7 Global Non-Drug Eluting Device Market Size, By Other Applications, By Value, 2020H-2030F (USD Million & CAGR)
3.8 Global Non-Drug Eluting Device Market Segmentation: By Material Type
3.8.1 Global Non-Drug Eluting Device Market, By Material Type Overview
3.8.2 Global Non-Drug Eluting Device Market Attractiveness Index, By Material Type (2025-2030)
3.8.3 Global Non-Drug Eluting Device Market Size, By Cobalt-Chromium , By Value, 2020H-2030F (USD Million & CAGR)
3.8.4 Global Non-Drug Eluting Device Market Size, By Stainless Steel, By Value, 2020H-2030F (USD Million & CAGR)
3.8.5 Global Non-Drug Eluting Device Market Size, By Nitinol, By Value, 2020H-2030F (USD Million & CAGR)
3.8.6 Global Non-Drug Eluting Device Market Size, By Other Material Types, By Value, 2020H-2030F (USD Million & CAGR)
3.9 Global Non-Drug Eluting Device Market Segmentation: By End-User
3.9.1 Global Non-Drug Eluting Device Market, By End-User Overview
3.9.2 Global Non-Drug Eluting Device Market Attractiveness Index, By End-User (2025-2030)
3.9.3 Global Non-Drug Eluting Device Market Size, By Hospitals & Clinics , By Value, 2020H-2030F (USD Million & CAGR)
3.9.4 Global Non-Drug Eluting Device Market Size, By Ambulatory Surgical Centers, By Value, 2020H-2030F (USD Million & CAGR)
4. Non-Drug Eluting Device Market, Region Analysis
4.1 Regional Coverage of the Study
4.2 Regional Snapshot

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

MENAFN31102024004107003653ID1108838490